West Pharma (WST) Misses Q1 EPS by 2c, Beats on Revenues; Offers FY18 EPS/Revenue Mid-Point Outlooks Above Consenus
Go back to West Pharma (WST) Misses Q1 EPS by 2c, Beats on Revenues; Offers FY18 EPS/Revenue Mid-Point Outlooks Above Consenus| WEST PHARMACEUTICAL SERVICES, Inc. (NYSE: WST) | Delayed: 363.16 -3.44 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $366.60 | 52 Week High | $84.33 | |||
| Open | $366.59 | 52 Week Low | $53.88 | |||
| Day High | $366.86 | P/E | 231.31 | |||
| Day Low | $360.48 | EPS | $1.57 | |||
| Volume | 158,872 | |||||
